1. Home
  2. ESLA vs PXLW Comparison

ESLA vs PXLW Comparison

Compare ESLA & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESLA
    SELLHOLDBUYas of 10 hours ago
  • PXLW
    SELLHOLDBUYas of 10 hours ago
  • Stock Information
  • Founded
  • ESLA 2021
  • PXLW 1997
  • Country
  • ESLA United States
  • PXLW United States
  • Employees
  • ESLA N/A
  • PXLW N/A
  • Industry
  • ESLA Biotechnology: Biological Products (No Diagnostic Substances)
  • PXLW Semiconductors
  • Sector
  • ESLA Health Care
  • PXLW Technology
  • Exchange
  • ESLA Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • ESLA 41.6M
  • PXLW 42.4M
  • IPO Year
  • ESLA N/A
  • PXLW 2000
  • Fundamental
  • Price
  • ESLA $1.16
  • PXLW $0.85
  • Analyst Decision
  • ESLA
  • PXLW Strong Buy
  • Analyst Count
  • ESLA 0
  • PXLW 3
  • Target Price
  • ESLA N/A
  • PXLW $2.17
  • AVG Volume (30 Days)
  • ESLA 16.0K
  • PXLW 413.4K
  • Earning Date
  • ESLA 02-12-2025
  • PXLW 02-06-2025
  • Dividend Yield
  • ESLA N/A
  • PXLW N/A
  • EPS Growth
  • ESLA N/A
  • PXLW N/A
  • EPS
  • ESLA N/A
  • PXLW N/A
  • Revenue
  • ESLA N/A
  • PXLW $54,190,000.00
  • Revenue This Year
  • ESLA N/A
  • PXLW N/A
  • Revenue Next Year
  • ESLA N/A
  • PXLW $22.09
  • P/E Ratio
  • ESLA N/A
  • PXLW N/A
  • Revenue Growth
  • ESLA N/A
  • PXLW N/A
  • 52 Week Low
  • ESLA $0.63
  • PXLW $0.61
  • 52 Week High
  • ESLA $3.23
  • PXLW $3.08
  • Technical
  • Relative Strength Index (RSI)
  • ESLA 50.29
  • PXLW 61.57
  • Support Level
  • ESLA $1.05
  • PXLW $0.68
  • Resistance Level
  • ESLA $1.27
  • PXLW $0.75
  • Average True Range (ATR)
  • ESLA 0.14
  • PXLW 0.06
  • MACD
  • ESLA -0.01
  • PXLW 0.01
  • Stochastic Oscillator
  • ESLA 46.67
  • PXLW 89.21

Stock Price Comparison Chart: ESLA vs PXLW

ESLA
PXLW
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022ESLA VS PXLW

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use